Enabling Protein Degradation Drug Discovery

Home » News & Events » Archives for Featured

Medivir licenses USP7 program to Ubiquigent

Posted on February 10th, 2021 in News
Dundee, UK 10th February 2021 — Ubiquigent Limited (Ubiquigent) announced today that it has entered into a license agreement with Medivir AB (Nasdaq Stockholm: MVIR) for Medivir’s preclinical USP7 research program. Under the terms of the agreement, Medivir has granted… Read more

Ubiquigent Continues Drug Discovery Collaboration with Bristol Myers Squibb

Posted on June 17th, 2020 in News
Dundee, UK, 17th June 2020: Ubiquigent Limited (Ubiquigent) today announced the continuation of a collaboration with Bristol Myers Squibb. The collaboration, originally between Ubiquigent and Celgene, will allow Bristol Myers Squibb tocapitalise on the strength and breadth of Ubiquigent’s deubiquitylase (DUB)… Read more